GI Surgery – Stomach and Duodenum
Review | Hereditary colorectal, gastric, and pancreatic cancer
18 May, 2023 | 13:43h | UTCHereditary colorectal, gastric, and pancreatic cancer: comprehensive review – BJS Open
Commentary on Twitter
Have a🔎at our latest comprehensive review covering all u need to know📜about hereditary 🧬colorectal, gastric & pancreatic🦀! https://t.co/y1LL0DNRiy@Adductor @DrRABurkhart #SoMe4Surgery #StepUp4CRC #SurgEd #MedTwitter @BJSAcademy @BJSurgery @juliomayol @young_bjs Great read! pic.twitter.com/JmmOmMBydO
— BJS Open (@BjsOpen) May 11, 2023
Review | Helicobacter pylori infection
2 May, 2023 | 13:37h | UTCHelicobacter pylori infection – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
A Primer published by @DiseasePrimers summarizes the epidemiology, pathophysiology, diagnosis and management of Helicobacter pylori infection, and discusses patient quality of life and open research questions. https://t.co/WawWpSGBU9 pic.twitter.com/ghFTbyp0ln
— Nature Portfolio (@NaturePortfolio) April 24, 2023
Cohort Study | Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer
17 Apr, 2023 | 12:57h | UTCCancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study – The Lancet Oncology (link to abstract – $ for full-text)
Commentary: Endoscopic Surveillance in Patients at Risk for Hereditary Diffuse Gastric Cancer – The ASCO Post
RCT | Over-the-scope clips show lower rebleeding rates in nonvariceal GI bleeding
6 Apr, 2023 | 12:57h | UTCComparison of Over-the-Scope Clips to Standard Endoscopic Treatment as the Initial Treatment in Patients With Bleeding From a Nonvariceal Upper Gastrointestinal Cause: A Randomized Controlled Trial – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Over-the-Scope Clip Beneficial for Nonvariceal Upper GI Bleeding – HealthDay
Commentary on Twitter
A new RCT found that over-the-scope-clips may be more effective than standard treatment for some patients with nonvariceal upper #GastrointestinalBleeding: https://t.co/GWG70CWmlt pic.twitter.com/Foq2qQZTEc
— Annals of Int Med (@AnnalsofIM) March 7, 2023
Brief Review | What every gastroenterologist should know about gastrointestinal neuroendocrine tumors
4 Apr, 2023 | 13:29h | UTC
Gastric Cancer: the combined impact of H. pylori infection and pathogenic gene variants
3 Apr, 2023 | 13:51h | UTCHelicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: H. Pylori Infection Negatively Modifies Genetically Increased Risk for Gastric Cancer – Physician’s Weekly
Commentary on Twitter
Infection with Helicobacter pylori is known to confer a risk of gastric cancer. In this study, persons who carried certain genetic variants and were infected with H. pylori had an excess risk of gastric cancer. https://t.co/jIcUiYu14G#genetics pic.twitter.com/jY4H1Mq6dO
— NEJM (@NEJM) March 29, 2023
Guidelines for Gastric Cancer | An evidence-based, multidisciplinary approach
22 Mar, 2023 | 13:33h | UTC
RCT | Comparable 5-year relapse-free survival for laparoscopic vs. open distal gastrectomy in advanced gastric cancer
22 Mar, 2023 | 13:27h | UTCSummary: The JLSSG0901 randomized clinical trial aimed to compare the 5-year survival outcomes of laparoscopy-assisted distal gastrectomy (LADG) and open distal gastrectomy (ODG) with D2 lymph node dissection for locally advanced gastric cancer.
The study involved 507 patients from 37 institutes in Japan. The primary endpoint was 5-year relapse-free survival. The results showed that the 5-year relapse-free survival rates were 73.9% and 75.7% for the ODG and LADG groups, respectively, confirming the noninferiority of LADG, and no significant differences were observed in severe postoperative complications between the two groups.
The study concluded that LADG with D2 lymph node dissection, when performed by qualified surgeons, was proven noninferior to ODG, and could become a standard treatment for locally advanced gastric cancer.
Article: Five-Year Survival Outcomes of Laparoscopy-Assisted vs Open Distal Gastrectomy for Advanced Gastric Cancer: The JLSSG0901 Randomized Clinical Trial – JAMA Surgery (link to abstract – $ for full-text)
Related:
Commentary on Twitter
Study results provide robust evidence suggesting that laparoscopic gastrectomy for locally advanced gastric cancer may be an appropriate treatment approach when performed by skilled surgeons. https://t.co/Dvnzk5YI9u pic.twitter.com/GDCdT4DJhp
— JAMA Surgery (@JAMASurgery) March 15, 2023
M-A | Laparoscopic vs. open distal gastrectomy for locally advanced gastric cancer
15 Mar, 2023 | 14:52h | UTCRelated:
Review | Analysis of deprescription strategies of proton pump inhibitors in primary care
7 Mar, 2023 | 12:42h | UTCRelated:
Deprescribing proton pump inhibitors – Australian Journal of General Practice
Review | Platelet aggregation inhibitors and anticoagulants in gastroenterological and visceral surgical procedures
1 Mar, 2023 | 14:03h | UTC
Guideline | Diagnosis and treatment of Helicobacter pylori
24 Feb, 2023 | 13:53h | UTCRelated:
RCT | Laparoscopic proximal gastrectomy with double-tract reconstruction vs. total gastrectomy in upper-third early gastric cancer
23 Feb, 2023 | 13:29h | UTCSummary: This randomized trial examined whether laparoscopic proximal gastrectomy with double-tract reconstruction (LPG-DTR) is a superior surgical treatment compared to laparoscopic total gastrectomy (LTG) for patients with early gastric cancer (GC) in the upper third of the stomach. The study found that LPG-DTR resulted in significantly decreased amounts of vitamin B12 supplementation, but no significant difference in hemoglobin change compared to LTG. The study also found no difference in complication rates or overall and disease-free survival rates between the two groups. The study suggests that LPG-DTR may be a function-preserving procedure for the treatment of patients with upper-third early GC.
Commentary on Twitter
RCT: Proximal gastrectomy with double tract reconstruction had an advantage of less vitamin B12 supplementation than total gastrectomy similar complication rates and survival in patients with upper third early gastric cancer. https://t.co/tdAktJxkpL pic.twitter.com/5miUbb9Ia6
— JAMA Network Open (@JAMANetworkOpen) February 15, 2023
M-A | Efficacy and safety of drugs for gastroparesis
17 Feb, 2023 | 13:05h | UTCCommentaries:
Review finds only two efficacious medications to treat gastroparesis – ACP Gastroenterology
Two drug classes appear effective for gastroparesis treatment – MDedge
Commentary from the author on Twitter (thread – click for more)
Our latest (and definitely last!) paper of 2022 is now published online in @AGA_Gastro and is a network meta-analysis of drugs in gastroparesis:https://t.co/kpz8nH6ekT
— Alexander Ford (@alex_ford12399) December 26, 2022
Complications of diagnostic upper gastrointestinal endoscopy: recognition, assessment and management
7 Feb, 2023 | 13:41h | UTC
Review | Prevention and management of minor complications in percutaneous endoscopic gastrostomy
7 Feb, 2023 | 13:39h | UTC
Rates of antimicrobial resistance in Helicobacter pylori isolates across the US and Europe
6 Feb, 2023 | 13:12h | UTCCommentary: Time to ditch clarithromycin for H. pylori? – MDedge
Commentary on Twitter
New #RedJournal study by Mégraud, et al., shows high antibiotic resistance rates in #Hpylori isolates across the US & EU and the need for antibiotic resistance surveillance and novel treatment strategies for H. pylori.
📕 Read more: https://t.co/JT6P0MnEdW@umfoodoc @cwhowden pic.twitter.com/5FeV3Wj6Dw
— AJG – The American Journal of Gastroenterology (@AmJGastro) November 14, 2022
M-A | Short-and long-term outcomes of laparoscopic versus open gastrectomy in patients with gastric cancer
2 Feb, 2023 | 14:36h | UTC
M-A | Proximal gastrectomy with double-tract-reconstruction vs. total gastrectomy in gastric and gastroesophageal junction cancer patients
27 Jan, 2023 | 11:54h | UTC
ACG Clinical Guideline | Diagnosis and management of gastrointestinal subepithelial lesions
18 Jan, 2023 | 14:39h | UTC
RCT | Second-line levofloxacin-based quadruple therapy vs. bismuth-based quadruple therapy for Helicobacter pylori eradication
12 Jan, 2023 | 13:06h | UTCSecond-line levofloxacin-based quadruple therapy versus bismuth-based quadruple therapy for Helicobacter pylori eradication and long-term changes to the gut microbiota and antibiotic resistome: a multicentre, open-label, randomised controlled trial – The Lancet Gastroenterology & Hepatology (link to abstract – $ for full-text)
Commentary on Twitter
New research – Liou et al – Second-line levofloxacin-based quadruple therapy vs bismuth-based quadruple therapy for H pylori eradication and long-term changes to the gut #microbiota and antibiotic resistome: an RCThttps://t.co/Aipu3TRyFr#Hpylori #microbiome #AMR @emadelomar pic.twitter.com/aeFMAI3FCj
— The Lancet Gastroenterology & Hepatology (@LancetGastroHep) December 20, 2022
RCT | Assessment of spleen-preserving hilar lymphadenectomy for advanced proximal gastric cancer without invasion into the greater curvature.
15 Dec, 2022 | 13:30h | UTCAssessment of Laparoscopic Spleen-Preserving Hilar Lymphadenectomy for Advanced Proximal Gastric Cancer Without Invasion Into the Greater Curvature: A Randomized Clinical Trial – JAMA Surgery (link to abstract – $ for full-text)
See also: Visual Abstract and Video Summary
Brief Review | Diagnosis and management of gastroparesis.
12 Dec, 2022 | 12:35h | UTCDiagnosis and Management of Gastroparesis – The American Journal of Gastroenterology
Related:
Worldwide prevalence and burden of gastroparesis-like symptoms.
ACG Clinical Guideline: Gastroparesis – The American Journal of Gastroenterology
Post-trial follow-up | Bursectomy vs. omentectomy alone for resectable gastric cancer.
12 Dec, 2022 | 12:26h | UTCFive-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001) – British Journal of Surgery (link to abstract – $ for full-text)
Review | Update on the management of upper gastrointestinal bleeding.
20 Oct, 2022 | 12:29h | UTCUpdate on the management of upper gastrointestinal bleeding – BMJ Medicine